During atrial fibrillation, myofibroblasts and cardiomyocytes release matrix metalloproteinases (MMPs), which degrade the extracellular matrix (ECM) and release cryptic epitopes and TGF-β from the ECM12. The gene discussed is TGFB1; the disease is atrial fibrillation.